The Asia-Pacific Contrast Injector Market was worth USD 71.76 million in 2016 and is projected to be growing at a CAGR of 11.5%, to touch USD 123.67 million by 2021.
A medical contrast medium is a substance used to enhance the contrast of fluids or structures within the body, for medical imaging. The delivery of these media is most efficient and effective by the use of a medical device known as a power injector or contrast injector.
The functioning of a contrast injector involves a blend of overlapping processes from the areas of pressure, thermal, electricity, rheology, viscosity, syringe, catheter and computer technologies. Contrast Injectors have varied applications in the fields of computed tomography, interventional radiology and magnetic resonance imaging (MRI) The growth of the Asia-Pacific Contrast Injector Market is majorly driven by the increasing presence of international players in the region to tap the humongous market potential. Market growth is further augmented by the increasing approvals for various contrast agents in the countries of the Asia-Pacific, and the environment of developing economies such as India and China is favourable for market growth, which have led to increased presence of private and public diagnostic centres.
View full report @ http://www.marketdataforecast.com/market-reports/asia-pacific-contrast-injector-market-3046/
The factors inhibiting market growth in the region include the side effects and side reactions associated with the use of contrast media. The Asia-Pacific Contrast Injector Market is segmented on the basis of Product, Application and Geography. Based on the Product, the Contrast Injector market is allocated into injector systems, consumables, and accessories. The injector systems segment is further distributed into CT injector systems, MRI injector systems, and angiography injector systems. The consumables segment is further segmented into injector heads, syringes, tubing, and other consumables (scan bags, valves, vials, and spikes). The injector heads segment is further categorized into single head injectors, dual head injectors, and syringeless injectors. On the basis of application, the contrast injector market is segmented into radiology, interventional cardiology, and interventional radiology. The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia.
Asia-Pacific is a fast developing Contrast Injector Market which is expected to grow at the highest CAGR, due to the availability of massive untapped markets and enormous population base. Factors such as growing contrast media approvals and growing diagnostic infrastructure in countries such as India and China are expected to lead the growth of the market in this region. Further, rapid expansion by leading market players to access the untapped markets in the region, is expected to boost the market growth in the region.
Download free [email protected]
The significant players in the Asia-Pacific Contrast Injector Market include Bracco Imaging S.p.A. (Italy), Bayer HealthCare (Germany), Guerbet Group (France), Medtron AG (Germany), ulrich GmbH & Co. KG (Germany), GE Healthcare (U.S.), AngioDynamics (U.S.), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device Technology Co., Ltd. (China), VIVID IMAGING (China), and Apollo RT Co., Ltd. (China).
• Injector Systems
• CT Injector Systems
• MRI Injector Systems
• Angiography Injector Systems
• Injector Heads
• Other Consumables
• Y-o-Y Growth Analysis, By Product
• Market Attractiveness Analysis, By Product
• Market Share Analysis, By Product
• Interventional Cardiology
• Interventional Radiology
• Y-o-Y Growth Analysis, By Application
• Market Attractiveness Analysis, By Application
• Market Share Analysis, By Application
Inquire before [email protected]